Investigator

Marc Remond

Research Fellow · The University of Newcastle, College of Health, Medicine and Wellbeing

Research Interests

MRMarc Remond
Papers(1)
Pregnancy‐associated …
Collaborators(2)
Nadom SafiPenelope Fotheringham
Institutions(1)
University Of Newcast…

Papers

Pregnancy‐associated gynecological cancer in New South Wales, Australia 1994–2013: A population‐based historical cohort study

AbstractIntroductionPregnancy‐associated gynecological cancer (PAGC) refers to cancers of the ovary, uterus, fallopian tube, cervix, vagina, and vulva diagnosed during pregnancy or within 12 months postpartum. We aimed to describe the incidence of, and perinatal outcomes associated with, invasive pregnancy‐associated gynecological cancer.Material and methodsWe conducted a population‐based historical cohort study using linked data from New South Wales, Australia. We included all women who gave birth between 1994 and 2013, with a follow‐up period extending to September 30, 2018. Three groups were analyzed: a gestational PAGC group (women diagnosed during pregnancy), a postpartum PAGC group (women diagnosed within 1 year of giving birth), and a control group (women with control diagnosis during pregnancy or within 1 year of giving birth). We used generalized estimation equations to compare perinatal outcomes between study groups.ResultsThere were 1 786 137 deliveries during the study period; 70 women were diagnosed with gestational PAGC and 191 with postpartum PAGC. The incidence of PAGC was 14.6/100 000 deliveries and did not change during the study period. Women with gestational PAGC (adjusted odds ratio [aAOR] 6.81, 95% confidence interval [CI] 2.97–15.62) and with postpartum PAGC (aOR 2.65, 95% CI 1.25–5.61) had significantly increased odds of a severe maternal morbidity outcome compared with the control group. Babies born to women with gestational PAGC were more likely to be born preterm (aOR 3.11, 95% CI 1.47–6.59) and were at increased odds of severe neonatal complications (aOR 3.47, 95% CI 1.45–8.31) compared with babies born to women without PAC.ConclusionsThe incidence of PAGC has not increased over time perhaps reflecting, in part, the effectiveness of cervical screening and early impacts of human papillomavirus vaccination programs in Australia. The higher rate of preterm birth among the gestational PAGC group is associated with adverse outcomes in babies born to these women.

27Works
1Papers
2Collaborators
Rheumatic Heart DiseaseEarly Detection of CancerPapillomavirus InfectionsUterine Cervical Neoplasms

Positions

2022–

Research Fellow

The University of Newcastle · College of Health, Medicine and Wellbeing

2019–

Research Coordinator

The University of Newcastle · College of Health, Medicine and Wellbeing

2017–

Researcher

University of Technology Sydney · Graduate School of Health

2015–

Project Manager

Baker IDI Heart and Diabetes Institute · Aboriginal Health

Education

2015

PhD

James Cook University Cairns Campus · School of Medicine and Dentistry

1996

BSc (Hons)

University of Sydney · School of Biological Sciences

1990

LlB (Hons)

University of Sydney · Faculty of Law

Country

AU